All Circulars (26079)
Browse all regulatory circulars from India’s major stock exchanges and market regulator. Navigate by source using the buttons below or explore individual circulars in the grid.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces listing of 2,657,518 units of Aditya Birla Sun Life BSE Top 10 Banks ETF (Scrip Code: 544719) in the 'B' Group, effective … | |||||||||||||||
BSE announces listing of 2,657,518 units of Aditya Birla Sun Life BSE Top 10 Banks ETF (Scrip Code: 544719) in the 'B' Group, effective March 4, 2026, tracking the BSE Top 10 Banks Total Return Index.
| |||||||||||||||
BSE announces listing of units of Aditya Birla Sun Life BSE Top 10 Banks ETF (Scrip Code: 544719, ISIN: INF209KC1670) effective March 4, … | |||||||||||||||
BSE announces listing of units of Aditya Birla Sun Life BSE Top 10 Banks ETF (Scrip Code: 544719, ISIN: INF209KC1670) effective March 4, 2026, tracking the BSE Top 10 Banks Total Return Index under Group B.
| |||||||||||||||
NSE notifies listing of 2,657,518 units of Aditya Birla Sun Life BSE Top 10 Banks ETF (symbol: ABSL10BANK) effective March 04, 2026, with an … | |||||||||||||||
NSE notifies listing of 2,657,518 units of Aditya Birla Sun Life BSE Top 10 Banks ETF (symbol: ABSL10BANK) effective March 04, 2026, with an issue price of Rs. 182.46 per unit.
| |||||||||||||||
SEBI modifies the General Remittance Order issued under Recovery Certificate No. 4355 of 2021 against Venmax Drugs and Pharmaceuticals … | |||||||||||||||
SEBI modifies the General Remittance Order issued under Recovery Certificate No. 4355 of 2021 against Venmax Drugs and Pharmaceuticals Limited, adjusting recovery enforcement terms.
| |||||||||||||||
SEBI issues a modification to the Notice of Attachment under Recovery Certificate No. 4355 of 2021 against Venmax Drugs and Pharmaceuticals … | |||||||||||||||
SEBI issues a modification to the Notice of Attachment under Recovery Certificate No. 4355 of 2021 against Venmax Drugs and Pharmaceuticals Limited, amending previously attached assets or attachment details in ongoing recovery proceedings.
| |||||||||||||||
BSE notifies trading members of the new ISIN number INE343X01026 for Meera Industries Ltd following sub-division of equity shares from … | |||||||||||||||
BSE notifies trading members of the new ISIN number INE343X01026 for Meera Industries Ltd following sub-division of equity shares from Rs.10/- to Rs.5/-, effective from ex-date 06-03-2026.
| |||||||||||||||
BSE notifies trading members of the new ISIN INE343X01026 assigned to Meera Industries Ltd following sub-division of equity shares from … | |||||||||||||||
BSE notifies trading members of the new ISIN INE343X01026 assigned to Meera Industries Ltd following sub-division of equity shares from Rs.10/- to Rs.5/-, effective from ex-date March 6, 2026.
| |||||||||||||||
BSE assigns new ISIN INE343X01026 to MEERA INDUSTRIES LTD following sub-division of equity shares from Rs.10/- to Rs.5/-, effective from … | |||||||||||||||
BSE assigns new ISIN INE343X01026 to MEERA INDUSTRIES LTD following sub-division of equity shares from Rs.10/- to Rs.5/-, effective from ex-date March 06, 2026.
| |||||||||||||||
NSE admits privately placed commercial papers from 10 companies including Sundaram Finance, HDB Financial Services, Cholamandalam, Muthoot … | |||||||||||||||
NSE admits privately placed commercial papers from 10 companies including Sundaram Finance, HDB Financial Services, Cholamandalam, Muthoot Finance, Kotak Securities, and others to dealings on the Debt Market Segment effective March 2, 2026.
| |||||||||||||||
NSE notifies listing of further issued securities for 14 companies including HDFC Bank, ICICI Bank, Wipro, Tata Elxsi, and E2E Networks, … | |||||||||||||||
NSE notifies listing of further issued securities for 14 companies including HDFC Bank, ICICI Bank, Wipro, Tata Elxsi, and E2E Networks, effective March 04, 2026. Issues include ESOP allotments and one QIP allotment.
| |||||||||||||||